2008
DOI: 10.1007/978-3-540-77496-9_13
|View full text |Cite
|
Sign up to set email alerts
|

Noninvasive Cell Tracking

Abstract: Cell-based therapies may gain future importance in defeating different kinds of diseases, including cancer, immunological disorders, neurodegenerative diseases, cardiac infarction and stroke. In this context, the noninvasive localization of the transplanted cells and the monitoring of their migration can facilitate basic research on the underlying mechanism and improve clinical translation. In this chapter, different ways to label and track cells in vivo are described. The oldest and only clinically establishe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
25
0
1

Year Published

2009
2009
2016
2016

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(27 citation statements)
references
References 65 publications
1
25
0
1
Order By: Relevance
“…Cell therapy strategies have been evaluated for treatment of stroke (involving stereotactically injected human neuronal cells into the brains of patients with motor deficits due to stroke) (228), Parkinson's disease (intrastriatal transplantation of fetal mesencephalic tissue) (251), and cancer (via the in vitro loading of dendritic cells with tumor antigens and then readministering the cells to the subject) (207,278). Most cell therapies have only demonstrated limited success, partly due to transplanted cells failing to differentiate into the functioning cells of interest (207), and also due to the long list of unanswered questions concerning these thera- …”
Section: E Cell Trackingmentioning
confidence: 99%
See 1 more Smart Citation
“…Cell therapy strategies have been evaluated for treatment of stroke (involving stereotactically injected human neuronal cells into the brains of patients with motor deficits due to stroke) (228), Parkinson's disease (intrastriatal transplantation of fetal mesencephalic tissue) (251), and cancer (via the in vitro loading of dendritic cells with tumor antigens and then readministering the cells to the subject) (207,278). Most cell therapies have only demonstrated limited success, partly due to transplanted cells failing to differentiate into the functioning cells of interest (207), and also due to the long list of unanswered questions concerning these thera- …”
Section: E Cell Trackingmentioning
confidence: 99%
“…Most cell therapies have only demonstrated limited success, partly due to transplanted cells failing to differentiate into the functioning cells of interest (207), and also due to the long list of unanswered questions concerning these thera- …”
Section: E Cell Trackingmentioning
confidence: 99%
“…Molecular imaging permits the temporal biodistribution of cells and related biological processes to be determined in a more meaningful manner throughout intact living subjects. [1][2][3] The molecular-imaging modalities have been used for tracking of labeled cells with a magnetic probe, 4 a fluorescent probe, 5 bioluminescence imaging (BLI), [6][7][8][9] or a radiotracer [10][11][12][13] in in vivo. Among these methods, imaging techniques using radiotracers have the highest sensitivity and are mostly quantitative.…”
Section: Introductionmentioning
confidence: 99%
“…SPIO contrast agents have been essentially used clinically for diagnosis of liver diseases, [83] whereas USPIO probes are generally used for lymph-node imaging, angiography, and bloodpool imaging [84][85][86][87][88][89]. Besides their clinical use, MRI contrast agents based on iron oxide nanoparticles are actually developed for studying biological processes: Significant contributions in this research area have illustrated the potential use of these particles for molecular and cellular imaging applications [78,80,82,[90][91][92][93][94].…”
Section: T 2 Nps-based Contrast Agentsmentioning
confidence: 99%